Category: Health
-
Canara HSBC Life Insurance Reports Healthy H1 FY27 Results: Embedded Value Reaches ₹7,622 Crore, Operating RoEV at 19.8%; Traditional Products Drive VNB Growth
New Business Premium stood at ₹1,984 crore, registering year-on-year growth of 16.1%Individual weighted premium income (WPI) of ₹1,117 crore, with year-on-year growth of 14.5%Value of New Business (VNB) stood at ₹266 crore, with year-on-year growth of 24% and new business margin of 21.3%Protection b…
-
Helfie Signs MOU with Homa Bay Kenya Ministry of Health for TB and Hypertension Screening Pilot
Population-scale pilot will target 100,000 of Homa Bay’s most vulnerable people across five sub-counties.MELBOURNE, Australia, Oct. 8, 2026 /PRNewswire/ — Helfie AI (“Helfie”), an AI-powered preventive network transforming global healthcare, today announced it has signed a Memorandum of Understandi…
-
OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration
LONDON, Oct. 7, 2026 /PRNewswire/ — OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product’s potential to tackle two major unmet needs in oncology: ADC resistance and the brain penetrati…
-
Stryker Launches Mako 4 SmartRobotics™ in India, Advancing the Next Generation of Robotic-Assisted Joint Replacement
NEW DELHI, Oct. 5, 2026 /PRNewswire/ — Stryker, a global leader in medical technologies, announced the launch of Mako 4 SmartRobotics™ (Mako 4), the fourth generation of Mako, bringing its latest robotic-arm assisted technology to India. Designed to support a more integrated clinical and operationa…
-
Emerald Clinical Trials Appoints Michael Stibilj as Chief Executive Officer to Lead Next Phase of Global Growth
SINGAPORE, Oct. 1, 2026 /PRNewswire/ — Emerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific, today announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. The appointment marks the beginning of the company’s nex…
-
IMG Completes Acquisition of World Nomads, Expanding Global Travel Insurance Distribution
SYDNEY, Oct. 1, 2026 /PRNewswire/ — IMG (International Medical Group) is excited to announce the successful completion of its acquisition of World Nomads.First announced in February 2026, the acquisition strengthens IMG’s global travel insurance distribution capabilities and expands its presence in…
-
Piramal Pharma Solutions and NP2 to Complete Cyclophosphamide Development Phase Next Month
Piramal and NP2 are set to complete the drug development phase of the generic cancer drug cyclophosphamide this October. The development and manufacturing activities are being conducted at Piramal’s dedicated sterile injectable facility in Lexington, Kentucky. This partnership addresses ongoing cycl…
-
Ontario Contributes $1.7 Million Investment to Advance Life Sciences Innovation at Piramal Pharma's Aurora Facility
Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure.With its investment through the Life Sciences Scale-Up Fund, the Ontario government is supporting healthcare innovation and reinforcing its province’s leadership position in t…
-
CAS announces collaboration with Novartis to advance AI-ready reaction informatics
Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data discovery and analysis COLUMBUS, Ohio, Sept. 29, 2026 /PRNewswire/ — CAS, a division of the American Chemical Society, today announced a collaboration with Novartis Biomedic…
-
A Right-Sided Heart, A 3kg Tumour: A Rare Surgery at Zydus Hospital, Ahmedabad Gives An 11-Year-Old a New Life
Maximally invasive to minimally invasive thoracic tumours: a typical week’s workAHMEDABAD, India, Sept. 25, 2026 /PRNewswire/ — Lung and thoracic cancers are rising rapidly in India with a sevenfold increase since the last decade. Nearly three-quarters of patients are being diagnosed only after the…
Latest News
About the Author
Your reliable go-to for precise and up-to-date information!
We are dedicated to accuracy, impartiality, and providing news as it unfolds, earning the trust of a wide audience. Keep up with real-time updates on the latest events and trends.